Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice

被引:41
|
作者
Fan, Yong [1 ,2 ]
Fang, Xin [1 ,3 ]
Tajima, Asako [1 ,2 ]
Geng, Xuehui [2 ]
Ranganathan, Sarangarajan [4 ]
Dong, Henry [2 ]
Trucco, Massimo [1 ,2 ]
Sperling, Mark A. [5 ]
机构
[1] Allegheny Hlth Network, Inst Cellular Therapeut, 11th Floor,South Tower,320 E North Ave, Pittsburgh, PA 15212 USA
[2] Univ Pittsburgh, Sch Med, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15261 USA
[3] Fujian Med Univ, Union Hosp, Dept Pediat, Fuzhou, Peoples R China
[4] UPMC, Childrens Hosp Pittsburgh, Dept Pathol, Pittsburgh, PA USA
[5] Univ Pittsburgh, Sch Med, Dept Pediat, Div Endocrinol, Pittsburgh, PA 15261 USA
来源
关键词
growth hormone receptor; hepatic steatosis; hepatocellular adenoma; NAFLD;
D O I
10.3389/fendo.2014.00218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common forms of chronic liver diseases closely associated with obesity and insulin resistance; deficient growth hormone (GH) action in liver has been implicated as a mechanism. Here, we investigated the evolution of NAFLD in aged mice with liver-specific GHR deletion. Methods: We examined glucose tolerance, insulin responsiveness, and lipid profiles in aged male mice (44-50 weeks) with GHRLD. We performed proteomics analysis, pathway based Superarray assay, as well as quantitative RT-PCR to gain molecular insight into the mechanism(s) of GHR-deficiency-mediated NAFLD. In addition, we examined the pathological changes of livers of aged GHRLD male mice. Results: The biochemical profile was consistent with that of the metabolic syndrome: abnormal glucose tolerance, impaired insulin secretion, and hyperlipidemia. RT-qPCR analysis of key markers of inflammation revealed a three- to fivefold increase in TNF alpha and CCL3, confirming the presence of inflammation. Expression of fibrotic markers (e.g., CoI1A2 and Col3A1) was significantly increased, together with a two- to threefold increase in TGF1 transcripts. Proteomics analyses showed a marked decrease of Mup1 and Selenbp2. In addition, pathway-analysis showed that the expression of cell cycle and growth relevant genes (i.e., Ccndl, Socs2, Socs3, and Egfr) were markedly affected in GHRLD liver. Microscopic analyses (H&E) of GHRLD livers revealed the presence of hepatic adenomas of different stages of malignancy. Conclusion: Abrogation of GH signaling in male liver leads to metabolic syndrome, hepatic steatosis, increased inflammation and fibrosis, and development of hepatic tumor. Since obesity, a common precursor of NAFLD, is a state of deficient GH secretion and action, the GHRLD model could be used to unravel the contribution of compromised hepatic GH signaling in these pathological processes, and help to identify potential targets for intervention.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Liver-specific Repin1 deficiency impairs transient hepatic steatosis in liver regeneration
    Abshagen, Kerstin
    Degenhardt, Bastian
    Liebig, Marie
    Wendt, Anna
    Genz, Berit
    Schaeper, Ute
    Stumvoll, Michael
    Hofmann, Ute
    Frank, Marcus
    Vollmar, Brigitte
    Kloeting, Nora
    SCIENTIFIC REPORTS, 2018, 8
  • [32] Liver-specific Repin1 deficiency impairs transient hepatic steatosis in liver regeneration
    Kerstin Abshagen
    Bastian Degenhardt
    Marie Liebig
    Anna Wendt
    Berit Genz
    Ute Schaeper
    Michael Stumvoll
    Ute Hofmann
    Marcus Frank
    Brigitte Vollmar
    Nora Klöting
    Scientific Reports, 8
  • [33] Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development
    Mueller, Kristina M.
    Themanns, Madeleine
    Friedbichler, Katrin
    Kornfeld, Jan-Wilhelm
    Esterbauer, Harald
    Tuckermann, Jan P.
    Moriggl, Richard
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 361 (1-2) : 1 - 11
  • [34] Disruption of FoxO1 Restores the Ability of Insulin to Regulate Hepatic Glucose Production in Liver-Specific Insulin Receptor Knockout (LIRKO) Mice
    O-Sullivan, InSug
    Li, Kang
    Wasserman, David
    Kahn, C. Ronald
    Schwartz, Michael W.
    Unterman, Terry G.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [35] Liver-specific thyroid hormone receptor-β agonism alleviates alcoholic steatohepatitis (ASH) in mice
    Shahi, Ambuj
    Yadav, Abhishek
    Rajak, Sangam
    Raza, Sana
    Tewari, Archana
    Gupta, Pratima
    Sinha, Rohit A.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 734
  • [36] Liver-specific androgen receptor knockout attenuates early liver tumor development in zebrafish
    Hankun Li
    Yan Li
    Jeng-Wei Lu
    Xiaojing Huo
    Zhiyuan Gong
    Scientific Reports, 9
  • [37] Impairment of Hepatic Growth Hormone and Glucocorticoid Receptor Signaling Causes Steatosis and Hepatocellular Carcinoma in Mice
    Mueller, Kristina M.
    Kornfeld, Jan-Wilhelm
    Friedbichler, Katrin
    Blaas, Leander
    Egger, Gerda
    Esterbauer, Harald
    Hasselblatt, Peter
    Schlederer, Michaela
    Haindl, Susanne
    Wagner, Kay-Uwe
    Engblom, David
    Haemmerle, Guenter
    Kratky, Dagmar
    Sexl, Veronika
    Kenner, Lukas
    Kozlov, Andrey V.
    Terracciano, Luigi
    Zechner, Rudolf
    Schuetz, Guenther
    Casanova, Emilio
    Pospisilik, J. Andrew
    Heim, Markus H.
    Moriggl, Richard
    HEPATOLOGY, 2011, 54 (04) : 1398 - 1409
  • [38] Liver-specific androgen receptor knockout attenuates early liver tumor development in zebrafish
    Li, Hankun
    Li, Yan
    Lu, Jeng-Wei
    Huo, Xiaojing
    Gong, Zhiyuan
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [39] Liver-specific FGFR4 knockdown in mice on an HFD increases bile acid synthesis and improves hepatic steatosis
    Moreau, Francois
    Brunao, Bruna Brasil
    Liu, Xiang -Yu
    Tremblay, Frederic
    Fitzgerald, Kevin
    Avila-Pacheco, Julian
    Clish, Clary
    Kahn, Ronald C.
    Softic, Samir
    JOURNAL OF LIPID RESEARCH, 2023, 64 (02)
  • [40] Liver-specific deletion of ROCK1 prevents hepatic steatosis in leptin-deficient ob/ob mice
    Lima, I. S.
    Lee, S. -H.
    Huang, H.
    Chung, M.
    Macedo, M.
    Kim, Y. -B.
    DIABETOLOGIA, 2016, 59 : S308 - S308